• History

Chronology

Delpharm has grown through the acquisition of plant from major big pharmas. With more than 600 millions units produced per year in a wide number of dosage forms, Delpharm is among the key drugs manufacturer in Europe. All the more, Delpharm is fully dedicated to pharma services for others : 100% of the turnover is for manufacturing and development for its customers. Priority is always given to customers.

2017 - Milano

Ex. Roche (Segrate)

2016 - Novara

Ex. Takeda

2015 - Dijon

Ex. Sanofi

2013 - Lyon

Ex. Pfizer

2012 - Gaillard

Ex. Bayer

2012 - Drogenbos

Ex. Laboratoires Besins

2011 - Huningue

Ex. Novartis

2008 - Reims

Ex. Boehringer Ingelheim

2008 - IDL

International Drug Licensing

2006 - Lille

Ex. Schering (Bayer)

2002 - Evreux

Ex. Pharmacia (Pfizer)

1994 - Brétigny

Ex. Syntex (Roche)

1988 - Tours

Ex. Delmas perfusion